PP

Parthajit Paul

Director Director DIN 07382059
DIN 07382059 First appointment Jan 2016 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 2016
Shareholding value Locked Premium profile

About Parthajit Paul

Data last updated:

Parthajit Paul has 10 years in corporate governance. Formerly with 1 company, such as Medanta Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07382059
Primary Designation Director
First Appointment 05 Jan 2016
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Whole-Time Director05 Jan 20162016Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medanta Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Parthajit Paul

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Parthajit Paul

Parthajit Paul has 10 years in corporate governance. Formerly with 1 company, such as Medanta Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Parthajit Paul is associated with 0 companies as a director.

Parthajit Paul has expertise in General Business.

Parthajit Paul has 10 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available